Postintroduction Study of Cost-Effectiveness of Pneumococcal Vaccine PCV10 from Public Sector Payer’s Perspective in the State of Santa Catarina, Brazil

ConclusionsThe vaccine was very cost-effective according to the World Health Organization criterion.
Source: Value in Health Regional Issues - Category: International Medicine & Public Health Source Type: research